Cogent Biosciences, Inc. (COGT)
34.69
-0.31
(-0.89%)
USD |
NASDAQ |
Sep 01, 16:00
34.69
0.00 (0.00%)
After-Hours: 17:59
Cogent Biosciences Cash from Investing (Quarterly) : 14.28M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.28M |
| March 31, 2026 | -36.46M |
| December 31, 2025 | -322.77M |
| September 30, 2025 | -155.05M |
| June 30, 2025 | 8.91M |
| March 31, 2025 | 69.38M |
| December 31, 2024 | 61.67M |
| September 30, 2024 | 60.19M |
| June 30, 2024 | -84.62M |
| March 31, 2024 | 1.044M |
| December 31, 2023 | 10.49M |
| September 30, 2023 | -90.54M |
| June 30, 2023 | -77.66M |
| March 31, 2023 | 59.88M |
| December 31, 2022 | 28.41M |
| September 30, 2022 | -151.54M |
| June 30, 2022 | -1.144M |
| March 31, 2022 | -0.441M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.433M |
| September 30, 2021 | -1.163M |
| June 30, 2021 | -0.123M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 8.42M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.013M |
| September 30, 2019 | 0.226M |
| June 30, 2019 | 7.996M |
| March 31, 2019 | 14.95M |
| December 31, 2018 | 15.00M |
| September 30, 2018 | 9.914M |
| June 30, 2018 | -41.37M |
| March 31, 2018 | 5.925M |
| December 31, 2017 | 4.90M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Apogee Therapeutics, Inc. | -381.86M |
| Erasca, Inc. | 19.49M |
| Moderna, Inc. | 329.00M |
| Arrowhead Pharmaceuticals, Inc. | 43.68M |
| Oncolytics Biotech, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -77.27M |
| Cash from Financing (Quarterly) | 2.955M |
| Free Cash Flow | -309.24M |
| Free Cash Flow Per Share (Quarterly) | -0.4539 |
| Free Cash Flow to Equity (Quarterly) | -83.25M |
| Free Cash Flow to Firm (Quarterly) | -76.42M |
| Free Cash Flow Yield | -5.76% |